Amarin Pharma, FDA Talk Settlement Of Off-Label Lawsuit After Injunction

(August 31, 2015, 12:45 PM EDT) -- NEW YORK — Amarin Pharma Inc. and the Food and Drug Administration are exploring the possibility of settling Amarin’s off-label speech lawsuit, counsel for the drug company told a New York...
To view the full article, register now.